Derivation and characterization of human fetal MSCs: An alternative cell source for large-scale production of cardioprotective microparticles
10.1016/j.yjmcc.2009.12.021
Saved in:
Main Authors: | Lai, R.C., Tan, S.S., Chen, T.S., Teh, B.J., Sidik, H., Lim, S.K., Arslan, F., Pasterkamp, G., de, Kleijn D.P.V., Tan, B., Tanavde, V., CHOO BOON HWA,ANDRE, Lee, M.M., Eng, J.K.L., Hwang, W.S., Lee, C.N., Oakley, R.M.E., Tan, K.H. |
---|---|
Other Authors: | BIOLOGICAL SCIENCES |
Format: | Article |
Published: |
2011
|
Subjects: | |
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/24188 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Characterization of the secretion of mesenchymal stem cells and its relevance to cardioprotection
by: LAI RUENN CHAI
Published: (2011) -
Cardioprotective effects of nitroparacetamol and paracetamol in acute phase of myocardial infarction in experimental rats
by: Zhu, Y.Z., et al.
Published: (2011) -
IMproving Preclinical Assessment of Cardioprotective Therapies (IMPACT) criteria: guidelines of the EU-CARDIOPROTECTION COST Action
by: Lecour, Sandrine, et al.
Published: (2022) -
Mesenchymal stem cell exosome: A novel stem cell-based therapy for cardiovascular disease
by: Lai, R.C., et al.
Published: (2014) -
Targeting mitochondrial fusion and fission proteins for cardioprotection
by: Hernandez-Resendiz, S., et al.
Published: (2021)